Fact CheckerSign in

NCT07100691Not yet recruitingPhase 4

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Preoperative Metoclopramide to Enhance Gastric Emptying in Patients on Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss: A Randomised Controlled Trial With Ultrasound Assessment

Source: ClinicalTrials.gov · Last updated 6 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a multicentre, investigator-blinded, randomised controlled trial evaluating whether the use of oral metoclopramide before surgery can reduce the amount of residual gastric content in patients who are taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss. These medications are known to slow down gastric emptying, which may increase the risk of pulmonary aspiration during anaesthesia. Patients will be randomly assigned to either receive metoclopramide 24 hours before surgery or continue with standard care. The primary outcome will be the presence or absence of residual gastric content on ultrasound before surgery. Secondary outcomes include nausea, vomiting, constipation, and any adverse effects of the medication.

Status (registry)
Not yet recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
First submitted
27 Jul 2025
Start date
1 Aug 2025
Primary completion date
31 May 2026
Lead sponsor
Mater Misericordiae University Hospital
Diseases
Obesity
NCT number
NCT07100691

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 80
  • From 1 Aug 2025 to the primary completion date, 31 May 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Urgent or emergency surgery, including trauma

Other illness

  • History of any gastric surgery
  • Diagnosis of Parkinson's disease
  • Allergy or intolerance to metoclopramide

Lab values

  • Poorly controlled diabetes (HbA1c \>69 mmol/mol)

Other

  • Inability to provide informed consent
  • Presence of hiatus hernia
  • Pregnancy
  • Inability to lie in the right lateral decubitus position
  • Patients taking chronic opioids

Who the study is looking for

  • Patients taking GLP-1 receptor agonists (for weight loss only)
  • Male and female patients aged 18 years or older
  • Able to provide written informed consent
  • ASA grade I-V
  • Scheduled for elective surgery with an expected overnight hospital stay

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Orthopaedic Hospital Cappagh
Coordinator of this site? Confirm its status
DublinIrelandUnknown status
Rotunda hospital
Coordinator of this site? Confirm its status
DublinIrelandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.